# Code 29349990: Other

EU customs tariff 2026

Web page: https://hscode.info/en/2026/29349990

- [29](https://hscode.info/en/2026/29.md) ORGANIC CHEMICALS
- [2934](https://hscode.info/en/2026/2934.md) Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds
- [293491](https://hscode.info/en/2026/293491.md) Other
- [293499](https://hscode.info/en/2026/293499.md) Other

## Codes

- [2934999004](https://hscode.info/en/2026/2934999004.md) Silthiofam (ISO) (CAS RN 175217-20-6) with a purity by weight of 98 % or more
- [2934999005](https://hscode.info/en/2026/2934999005.md) (S)-2-Methyl-1-(6-nitropyridin-3-yl)-4-(oxetan-3-yl)piperazine (CAS RN 1895867-67-0) with a purity by weight of 97 % or more
- [2934999006](https://hscode.info/en/2026/2934999006.md) Cis-[2-(2,4-Dichlorodiphenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4yl]methyl-4-methylbenzenesulfonate (CAS RN 134071-44-6) with a purity by weight of 99 % or more
- [2934999007](https://hscode.info/en/2026/2934999007.md) Cedazuridine (INN) (CAS RN 1141397-80-9) with a purity by weight of 99 % or more
- [2934999008](https://hscode.info/en/2026/2934999008.md) (R)-tert-butyl 2-(6-(5-chloro-2-((tetrahydro-2H-pyran-4-yl)amino)pyrimidin-4-yl)-1-oxoisoindolin-2-yl)propanoate (CAS RN 2095665-45-3) with a purity by weight of 98 % or more
- [2934999009](https://hscode.info/en/2026/2934999009.md) 3-[2-{(2R,3S)-3-[(1R)-1-{[tert-butyl(dimethyl)silyl]oxy}ethyl]-4-oxoazetidin-2-yl}propanoyl]-4,4-dimethyl-1,3-oxazolidin-2-one (isomeric mixture of CAS RNs 114341-89-8 and 114418-63-2) with a purity by weight of 99 % or more
- [2934999010](https://hscode.info/en/2026/2934999010.md) Fluralaner (INN) (CAS RN 864731-61-3)
- [2934999011](https://hscode.info/en/2026/2934999011.md) Aqueous solution of d(P-thio)(T-G-A-C-T-G-T-G-A-A-C-G-T-T-C-G-A-G-A-T-G-A) deoxyribonucleic acid (CAS RN 937402-51-2), containing by weight 15 % or more, but not more than 25 % of oligodeoxynucleotide
- [2934999012](https://hscode.info/en/2026/2934999012.md) Dimethomorph (ISO) (CAS RN 110488-70-5)
- [2934999013](https://hscode.info/en/2026/2934999013.md) (6S)-6-methyl-5,6-Dihydro-4H-thieno[2,3-b]thiopyran4-one-7,7-dioxide (CAS RN 148719-91-9) with a purity by weight of 98 % or more
- [2934999014](https://hscode.info/en/2026/2934999014.md) 2-Mercaptoadenosine (CAS RN 43157-50-2) with a purity by weight of 98 % or more
- [2934999016](https://hscode.info/en/2026/2934999016.md) Difenoconazole (ISO) (CAS RN 119446-68-3)
- [2934999017](https://hscode.info/en/2026/2934999017.md) (S)-4-(tert-butoxycarbonyl)-1,4-oxazepane-2-carboxylic acid (CAS RN 1273567-44-4) with a purity by weight of 95 % or more
- [2934999018](https://hscode.info/en/2026/2934999018.md) Methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2-(2-chloroacetyl)-1,3,4,9-tetrahydropyrido[5,4-b]indole-3-carboxylate (CAS RN 171489-59-1) with a purity by weight of 99 % or more
- [2934999019](https://hscode.info/en/2026/2934999019.md) (4R,6S)-6-Methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-ol (CAS RN 147128-77-6) with a purity by weight of 94 % or more
- [2934999020](https://hscode.info/en/2026/2934999020.md) Thiophene (CAS RN 110-02-1)
- [2934999021](https://hscode.info/en/2026/2934999021.md) Acesulfame potassium (potassium salt of 6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide; CAS RN 55589-62-3) ace-K
- [2934999022](https://hscode.info/en/2026/2934999022.md) 4-(Oxiran-2-ylmethoxy)-9H-carbazole (CAS RN 51997-51-4) with a purity by weight of 97 % or more
- [2934999024](https://hscode.info/en/2026/2934999024.md) Flufenacet (ISO) (CAS RN 142459-58-3) with a purity by weight of 95 % or more
- [2934999026](https://hscode.info/en/2026/2934999026.md) 4-Methylmorpholine 4-oxide in an aqueous solution (CAS RN 7529-22-8)
- [2934999027](https://hscode.info/en/2026/2934999027.md) 2-(4-Hydroxyphenyl)-1-benzothiophene-6-ol (CAS RN 63676-22-2)
- [2934999028](https://hscode.info/en/2026/2934999028.md) 11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride (CAS RN 111974-74-4)
- [2934999030](https://hscode.info/en/2026/2934999030.md) Dibenzo[b,f][1,4]thiazepin-11(10H)-one (CAS RN 3159-07-7)
- [2934999031](https://hscode.info/en/2026/2934999031.md) Thenoic acid (CAS RN 1918-77-0) with a purity by weight of 97 % or more
- [2934999032](https://hscode.info/en/2026/2934999032.md) (6R,7R)-Benzhydryl 3-hydroxy-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (CAS RN 54639-48-4) with a purity by weight of 95 % or more
- [2934999034](https://hscode.info/en/2026/2934999034.md) Benzyl 4-(oxetan-3-yl)piperazine-1-carboxylate (CAS RN 1254115-22-4) with a purity by weight of 99 % or more
- [2934999035](https://hscode.info/en/2026/2934999035.md) Nusinersen sodium (INNM) (CAS RN 1258984-36-9) with a purity by weight of 95 % or more
- [2934999036](https://hscode.info/en/2026/2934999036.md) Nadide phosphate (INNM) disodium salt (CAS RN 24292-60-2) with a purity by weight of 97 % or more
- [2934999037](https://hscode.info/en/2026/2934999037.md) 4-Propan-2-ylmorpholine (CAS RN 1004-14-4)
- [2934999038](https://hscode.info/en/2026/2934999038.md) 2-Chloro-9H-thioxanthen-9-one (CAS RN 86-39-5) with a purity by weight of 98 % or more
- [2934999039](https://hscode.info/en/2026/2934999039.md) 4-(Oxiran-2-ylmethoxy)-9H-carbazole (CAS RN 51997-51-4)
- [2934999040](https://hscode.info/en/2026/2934999040.md) 2,3-Pyrazinedicarboxylic anhydride (CAS RN 4744-50-7) with a purity by weight of 95 % or more
- [2934999041](https://hscode.info/en/2026/2934999041.md) 11-[4-(2-Chloro-ethyl)-1-piperazinyl]dibenzo(b,f)(1,4)thiazepine (CAS RN 352232-17-8)
- [2934999045](https://hscode.info/en/2026/2934999045.md) 4-[4-[(5s)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl] phenyl]-3-morpholinone, hydrochloride (CAS RN 898543-06-1) with a purity by weight of 98 % or more
- [2934999046](https://hscode.info/en/2026/2934999046.md) (6R-trans)-7-Amino-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (CAS RN 58909-56-1) with a purity by weight of 97 % or more
- [2934999047](https://hscode.info/en/2026/2934999047.md) 2,4-Diethyl-9H-thioxanthen-9-one (CAS RN 82799-44-8) with a purity by weight of 97 % or more
- [2934999048](https://hscode.info/en/2026/2934999048.md) Propan-2-ol -- 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine (1:2) dihydrate, (CAS RN 864743-41-9)
- [2934999049](https://hscode.info/en/2026/2934999049.md) Cytidine 5'-(disodium phosphate) (CAS RN 6757-06-8)
- [2934999050](https://hscode.info/en/2026/2934999050.md) Vutrisiran (INN) (CAS RN 1867157-35-4) with a purity by weight of 98 % or more
- [2934999051](https://hscode.info/en/2026/2934999051.md) Uridine 5'-triphosphate trisodium salt (CAS RN 19817-92-6) with a dry weight purity of 90 % or more
- [2934999055](https://hscode.info/en/2026/2934999055.md) Uridine (CAS RN 58-96-8) with a purity by weight of 98 % or more
- [2934999056](https://hscode.info/en/2026/2934999056.md) 1-[5-(2,6-Difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]ethanone (CAS RN 1173693-36-1)
- [2934999057](https://hscode.info/en/2026/2934999057.md) Dimethenamide-P (ISO) (CAS RN 163515-14-8) with a purity by weight of 93 % or more
- [2934999059](https://hscode.info/en/2026/2934999059.md) Dolutegravir (INN) (CAS RN 1051375-16-6) or dolutegravir sodium (CAS RN 1051375-19-9)
- [2934999060](https://hscode.info/en/2026/2934999060.md) DL-Homocysteine thiolactone hydrochloride (CAS RN 6038-19-3)
- [2934999061](https://hscode.info/en/2026/2934999061.md) 5-(1,2-dithiolan-3-yl)valeric acid (CAS RN 1077-28-7)
- [2934999063](https://hscode.info/en/2026/2934999063.md) (2b,3a,5a,16b,17b)-2-(morpholin-4-yl)-16-(pyrrolidin-1-yl)androstane-3,17-diol (CAS RN 119302-20-4)
- [2934999064](https://hscode.info/en/2026/2934999064.md) 2-Bromo-5-benzoylthiophene (CAS RN 31161-46-3)
- [2934999065](https://hscode.info/en/2026/2934999065.md) Benzo[b]thiophen-10-methoxycycloheptanone (CAS RN 59743-84-9) with a purity by weight of 98 % or more
- [2934999066](https://hscode.info/en/2026/2934999066.md) Tetrahydrothiophene-1,1-dioxide (CAS RN 126-33-0)
- [2934999067](https://hscode.info/en/2026/2934999067.md) 5-Chlorothiophene-2-carboxylic acid (CAS RN 24065-33-6)
- [2934999069](https://hscode.info/en/2026/2934999069.md) 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazol-2(3H)-one (CAS RN 1220696-32-1) with a purity by weight of 95 % or more
- [2934999070](https://hscode.info/en/2026/2934999070.md) 1,3,4-thiadiazolidine-2,5-dithione (CAS RN 1072-71-5) with a purity by weight of 95 % or more
- [2934999071](https://hscode.info/en/2026/2934999071.md) 3,4-Dichloro-1,2,5-thiadiazole (CAS RN 5728-20-1) with a purity by weight of 99 % or more
- [2934999072](https://hscode.info/en/2026/2934999072.md) 2-Trifluoromethyl-9-allyl-9-thioxanthen-ol (CAS RN 850808-70-7) with a purity by weight of 98 % or more
- [2934999074](https://hscode.info/en/2026/2934999074.md) 2-Isopropylthioxanthone (CAS RN 5495-84-1)
- [2934999075](https://hscode.info/en/2026/2934999075.md) (4R-cis)-1,1-Dimethylethyl-6-[2[2-(4-fluorophenyl)-5-(1-isopropyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate (CAS RN 125971-95-1)
- [2934999076](https://hscode.info/en/2026/2934999076.md) Nedosiran sodium (INNM) (CAS RN 2247026-22-6) with a purity by weight of 95 % or more
- [2934999077](https://hscode.info/en/2026/2934999077.md) Tazemetostat (INN) (CAS 1403254-99-8) with a purity by weight of 99 % or more and its salts
- [2934999078](https://hscode.info/en/2026/2934999078.md) Disodium uridine-5'-monophosphate (CAS RN 3387-36-8) with a purity by weight of 98 % or more
- [2934999081](https://hscode.info/en/2026/2934999081.md) 1-(4-aminophenyl)-5-(morpholin-4-yl)-2,3-dihydropyridin-6-one (CAS RN 1267610-26-3) with a purity by weight of 98 % or more
- [2934999082](https://hscode.info/en/2026/2934999082.md) Rel-(3aR,12bR)-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one (CAS RN 129385-59-7) with a purity by weight of 97 % or more
- [2934999083](https://hscode.info/en/2026/2934999083.md) Flumioxazin (ISO) (CAS RN 103361-09-7) of a purity by weight of 96 % or more
- [2934999085](https://hscode.info/en/2026/2934999085.md) Gilteritinib (INN) (CAS 1254053-43-4) with a purity by weight of 98 % or more and its salts
- [2934999086](https://hscode.info/en/2026/2934999086.md) Dithianon (ISO) (CAS RN 3347-22-6)
- [2934999087](https://hscode.info/en/2026/2934999087.md) 2,2'-(1,4-Phenylene)bis(4H-3,1-benzoxazin-4-one) (CAS RN 18600-59-4)
- [2934999088](https://hscode.info/en/2026/2934999088.md) (7S,9aS)-7-((benzyloxy)methyl)octahydropyrazino[2,1-c][1,4]oxazine dioxalate (CAS RN 1268364-46-0)
- [2934999089](https://hscode.info/en/2026/2934999089.md) 6R-[6α,7β(Z)]]-7-[2-Furyl(methoxyimino)acetamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (CAS RN 56271-94-4) with a purity by weight of 96 % or more
- [2934999090](https://hscode.info/en/2026/2934999090.md) Other

## Import duties and measures

| Origin | Duty | From | Until | Measure | Legal base |
| - | - | - | - | - | - |
| Faroe Islands (FO) | 0 % | 01-01-1997 |   | Tariff preference | Decision 0126/97 |
| Occupied palestinian Territory (PS) | 0 % | 01-01-2001 |   | Tariff preference | Decision 0430/97 |
| Andorra (AD) | 0 % | 01-01-2006 |   | Customs Union Duty | Decision 0680/90 |
| Türkiye (TR) | 0 % | 01-01-2006 |   | Customs Union Duty | Decision 0142/96 |
| EU-Switzerland agreement: re-imported goods (1007) | 0 % | 01-01-2007 |   | Tariff preference | Regulation 2840/72 |
| GSP+ (incentive arrangement for sustainable development and good governance) (2027) | 0 % | 01-01-2014 |   | Tariff preference | Regulation 0978/12 |
| GSP - General arrangements (2020) | 0 % | 01-01-2015 |   | Tariff preference | Regulation 0978/12 |
| Ecuador (EC) | 0 % | 01-01-2017 |   | Tariff preference | Decision 2369/16 |
| Chile (CL) | 0 % | 01-02-2025 |   | Tariff preference | Decision 3016/24 |
| Tunisia (TN) | 0 % | 01-03-1998 |   | Tariff preference | Decision 0238/98 |
| Morocco (MA) | 0 % | 01-03-2000 |   | Tariff preference | Decision 0204/00 |
| Lebanon (LB) | 0 % | 01-04-2006 |   | Tariff preference | Decision 0356/06 |
| Egypt (EG) | 0 % | 01-06-2004 |   | Tariff preference | Decision 0635/04 |
| EEA - European Economic Area (2012) | 0 % | 01-07-2007 |   | Tariff preference | Decision 0001/94 |
| Korea, Republic of (South Korea) (KR) | 0 % | 01-07-2011 |   | Tariff preference | Decision 0265/11 |
| Mexico (MX) | 0 % | 01-07-2016 |   | Tariff preference | Decision 0415/00 |
| ERGA OMNES (1011) | 0 % | 01-07-2016 |   | Suspension - goods for certain categories of ships, boats and other vessels and for drilling or production platforms | Regulation 2658/87 |
| United States (US) | 0 % | 01-07-2026 |   | Tariff preference | Regulation 1455/26 |
| Colombia (CO) | 0 % | 01-08-2013 |   | Tariff preference | Decision 0735/12 |
| Central America (2200) | 0 % | 01-08-2013 |   | Tariff preference | Decision 0734/12 |
| Viet Nam (VN) | 0 % | 01-08-2020 |   | Tariff preference | Decision 0753/20 |
| Algeria (DZ) | 0 % | 01-09-2005 |   | Tariff preference | Decision 0690/05 |
| Syria (SY) | 0 % | 01-11-1978 |   | Tariff preference | Regulation 2216/78 |
| Preferential origin in accordance with the Agreement in the form of an Exchange of Letters between the European Union and the Kingdom of Morocco on the amendment of Protocols 1 and 4 to the Euro-Mediterranean Agreement establishing an association between the European Communities and their Member States, of the one part, and the Kingdom of Morocco, of the other part. (2000) | 0 % | 03-10-2025 |   | Tariff preference | Decision 2022/25 |
| South Africa (ZA) | 0 % | 10-10-2016 |   | Tariff preference | Decision 1623/16 |
| Israel (IL) | 0 % | 16-05-2023 |   | Tariff preference | Decision 0855/09 |
| Switzerland (CH) | 0 % | 20-12-1972 |   | Tariff preference | Regulation 2840/72 |
| North Macedonia (MK) | 0 % | 01-01-2009 |   | Tariff preference | Decision 0239/04 |
| Bosnia and Herzegovina (BA) | 0 % | 01-01-2009 |   | Tariff preference | Decision 0474/08 |
| Ukraine (UA) | 0 % | 01-01-2016 |   | Tariff preference | Decision 0295/14 |
| Singapore (SG) | 0 % | 01-01-2027 |   | Tariff preference | Decision 1875/19 |
| Serbia (XS) | 0 % | 01-02-2010 |   | Tariff preference | Decision 0036/10 |
| Japan (JP) | 0 % | 01-02-2022 |   | Tariff preference | Decision 1907/18 |
| Peru (PE) | 0 % | 01-03-2013 |   | Tariff preference | Decision 0735/12 |
| Albania (AL) | 0 % | 01-04-2009 |   | Tariff preference | Decision 0332/09 |
| Kosovo (XK) | 0 % | 01-04-2016 |   | Tariff preference | Decision 0342/16 |
| Montenegro (ME) | 0 % | 01-05-2010 |   | Tariff preference | Decision 0224/10 |
| New Zealand (NZ) | 0 % | 01-05-2024 |   | Tariff preference | Decision 0244/24 |
| Mercosur (5500) | 5.2 % | 01-05-2026 | 31-12-2026 | Tariff preference | Decision 0183/26 |
| ERGA OMNES (1011) | Cond: B cert: Y-106 (29):; B cert: Y-110 (29):; B cert: Y-113 (29):; B (09): | 10-02-2023 |   | Import control on REACH | Regulation 1907/06 |
| Armenia (AM) | 0 % | 10-10-2026 | 11-10-2028 | Tariff preference | Regulation 2269/26 |
| Russian Federation (RU) | Cond: B cert: Y-759 (29):; B cert: Y-692 (29):; B (09): | 20-07-2025 |   | Import/export restriction - Common Military List (CML) goods | Regulation 0833/14 |
| Belarus (BY) | Cond: B cert: Y-759 (29):; B cert: Y-757 (29):; B cert: Y-758 (29):; B (09): | 20-07-2025 |   | Import control | Regulation 0765/06 |
| EU-Canada agreement: re-imported goods (1006) | 0 % | 21-09-2017 |   | Tariff preference | Decision 0037/17 |
| Canada (CA) | 0 % | 21-09-2017 |   | Tariff preference | Decision 0037/17 |
| Singapore (SG) | 0 % | 21-11-2022 | 31-12-2026 | Tariff preference | Decision 1875/19 |
| Melilla (XL) | 0 % | 01-01-1999 |   | Tariff preference | Accession act 0001/85 |
| San Marino (SM) | 0 % | 01-01-2006 |   | Customs Union Duty | Decision 0245/02 |
| GSP-EBA (Special arrangement for the least-developed countries - Everything But Arms) (2005) | 0 % | 01-01-2014 |   | Tariff preference | Regulation 0978/12 |
| Moldova, Republic of (MD) | 0 % | 01-01-2016 |   | Tariff preference | Decision 0492/14 |
| OCTs (Overseas Countries and Territories) (2080) | 0 % | 01-01-2021 |   | Tariff preference | Decision 1764/21 |
| United Kingdom (GB) | 0 % | 01-01-2021 |   | Tariff preference | Decision 2253/20 |
| Ghana (GH) | 0 % | 01-01-2027 |   | Tariff preference | Decision 1850/16 |
| Ceuta (XC) | 0 % | 01-07-1991 |   | Tariff preference | Accession act 0001/85 |
| Jordan (JO) | 0 % | 01-07-2006 |   | Tariff preference | Decision 0067/06 |
| Kenya (KE) | 0 % | 01-07-2024 |   | Tariff preference | Decision 1647/24 |
| Georgia (GE) | 0 % | 01-09-2014 |   | Tariff preference | Decision 0494/14 |
| ERGA OMNES (1011) | 2 EUR | 01-11-2026 |   | Union handling fee | Regulation 2108/26 |
| ERGA OMNES (1011) | 3 EUR | 01-11-2026 |   | Low-value consignment customs duty | Regulation 0382/26 |
| Ivory Coast (CI) | 0 % | 02-12-2019 |   | Tariff preference | Decision 0156/09 |
| Cameroon (CM) | 0 % | 04-08-2014 |   | Tariff preference | Decision 0152/09 |
| SADC EPA (1035) | 0 % | 10-10-2016 |   | Tariff preference | Decision 1623/16 |
| Eastern and Southern Africa States (1034) | 0 % | 14-05-2012 |   | Tariff preference | Decision 0196/12 |
| Ghana (GH) | 0 % | 15-12-2016 | 31-12-2026 | Tariff preference | Decision 1850/16 |
| Solomon Islands (SB) | 0 % | 17-05-2020 |   | Tariff preference | Decision 0729/09 |
| Papua New Guinea (PG) | 0 % | 20-12-2009 |   | Tariff preference | Decision 0729/09 |
| Ukraine (UA) | Cond: Y cert: Y-984 (29):; Y cert: N-954 (29):; Y cert: N-864 (29):; Y (09): | 24-06-2026 |   | Import control | Regulation 0263/22 |
| Ukraine (UA) | Cond: Y cert: Y-997 (26):; Y cert: N-864 (26):; Y cert: N-954 (26):; Y (06): | 24-06-2026 |   | Import control | Regulation 0692/14 |
| Fiji (FJ) | 0 % | 28-07-2014 |   | Tariff preference | Decision 0729/09 |
| CARIFORUM (1033) | 0 % | 29-12-2008 |   | Tariff preference | Decision 0805/08 |
| Samoa (WS) | 0 % | 31-12-2018 |   | Tariff preference | Decision 0729/09 |

Source: European Commission, TARIC, prepared by hscode.info. For many lookups or automated access: API and MCP server: https://hscode.info/en/developers.md
